Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion type Assertion NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_head.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion description "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion evidence source_evidence_literature NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion SIO_000772 22729835 NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion wasDerivedFrom befree-2016 NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.
- NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_assertion wasGeneratedBy ECO_0000203 NP992665.RA_hXI17Mzo0es7_cok9GoxCkEcihv0BrA4Tme2I8y4aI130_provenance.